Home/Filings/4/0000921895-19-002346
4//SEC Filing

Velan Capital, L.P. 4

Accession 0000921895-19-002346

CIK 0000835887other

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 3:45 PM ET

Size

10.8 KB

Accession

0000921895-19-002346

Insider Transaction Report

Form 4
Period: 2019-08-23
Velan Capital, L.P.
10% OwnerOther
Transactions
  • Purchase

    Common Stock, $0.0013 par value

    2019-08-26$4.30/sh+73,230$314,9117,418,672 total
  • Purchase

    Common Stock, $0.0013 par value

    2019-08-23$4.31/sh+130,826$563,6907,345,442 total
VENKATARAMAN BALAJI
10% OwnerOther
Transactions
  • Purchase

    Common Stock, $0.0013 par value

    2019-08-26$4.30/sh+73,230$314,9117,418,672 total
  • Purchase

    Common Stock, $0.0013 par value

    2019-08-23$4.31/sh+130,826$563,6907,345,442 total
Transactions
  • Purchase

    Common Stock, $0.0013 par value

    2019-08-26$4.30/sh+73,230$314,9117,418,672 total
  • Purchase

    Common Stock, $0.0013 par value

    2019-08-23$4.31/sh+130,826$563,6907,345,442 total
Footnotes (2)
  • [F1]This Form 4 is filed jointly by Velan Capital, L.P. ("Velan Capital"), Altiva Management Inc. ("Altiva"), and Balaji Venkataraman (collectively, the "Reporting Persons"). The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons disclaim beneficial ownership of the securities of the Issuer owned directly by other members of the Section 1(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, the Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
  • [F2]Securities owned directly by Velan Capital. Each of Altiva, as the general partner of Velan Capital, and Mr. Venkataraman, as the sole shareholder of Altiva, may be deemed to beneficially own the securities owned directly by Velan Capital.

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1
  • filerCIK 0001785731

Filing Metadata

Form type
4
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 3:45 PM ET
Size
10.8 KB